Close Menu

NEW YORK – Interpace Diagnostics reported this morning that its second quarter revenues rose 14 percent year over year, primarily due to the expansion of its existing products in the gastroenterological and endocrine space. 

For the three months ended June 30, the Parsippany, New Jersey-based firm reported revenues of $6.3 million, up from $5.5 million in the year-ago quarter but missing the consensus Wall Street estimate of $6.6 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.